Literature DB >> 23494112

Multiple drilling compared with standard core decompression for avascular necrosis of the femoral head in sickle cell disease patients.

Abdullah Al Omran1.   

Abstract

INTRODUCTION: Sickle cell disease (SCD) is the most common cause of avascular necrosis of femoral head (ANFH) in childhood. Advances in medical treatment led to improved life expectancy of such patients. SCD-related ANFH frequently progress to total collapse of the femoral head necessitating hip replacement. However, SCD patient are at more risk of intra- and post-operative complications and suboptimal outcome of total hip arthroplasty. Hence, it is imperative to preserve the femoral head as long as possible. PATIENTS AND METHODS: Between September 1992 and June 2007, 94 core decompression procedures were done to SCD patients who had modified Ficat stage I, IIA and IIB ANFH. Sixty one patients underwent a classical 8-mm drilling and 33 patients underwent 3.2-mm diameter MD technique. Patients were followed up for minimum of 2 years and were evaluated for clinical and Harris Hip Score improvement and for radiological progression.
RESULTS: All 19 hips that had Ficat stage I had significant reduction of pain and improvement of Harris Hip Score. No patient has required further surgery. Among the 39 hips with Ficat IIA at time of procedure, 80 % of hips which underwent CD and 78 % of MD cases had significant reduction of pain and improvement of HHS. Those patients showed no radiographic progression of the disease. The remaining, 20 % CD and 22 % MD eventually progressed radiologically to grade III or grade IV and had HHS less than 75 at last visit. In the 36 cases with Ficat IIB, 52 % CD and 52.8 % MC had significant reduction of pain and improvement of HHS. The rest showed no improvement in pain and function, and progressed to stage IV; 11 of them underwent THA and one patient refused surgery.
CONCLUSION: While multiple drilling is safer and less invasive than single coring in SCD, there is no statistically significant difference in outcome or complication rate between both procedures done for ANFH in patients with SCD.

Entities:  

Mesh:

Year:  2013        PMID: 23494112     DOI: 10.1007/s00402-013-1714-9

Source DB:  PubMed          Journal:  Arch Orthop Trauma Surg        ISSN: 0936-8051            Impact factor:   3.067


  16 in total

Review 1.  Osteonecrosis of the Hip: A Primer.

Authors:  Michelle J Lespasio; Nipun Sodhi; Michael A Mont
Journal:  Perm J       Date:  2019

2.  Investigating clinical failure of core decompression with autologous bone marrow mononuclear cells grafting for the treatment of non-traumatic osteonecrosis of the femoral head.

Authors:  Lihua Liu; Fuqiang Gao; Wei Sun; Yunting Wang; Qingyu Zhang; Bailiang Wang; Liming Cheng; Zi-Rong Li
Journal:  Int Orthop       Date:  2018-04-13       Impact factor: 3.075

3.  A current review of core decompression in the treatment of osteonecrosis of the femoral head.

Authors:  Todd P Pierce; Julio J Jauregui; Randa K Elmallah; Carlos J Lavernia; Michael A Mont; James Nace
Journal:  Curr Rev Musculoskelet Med       Date:  2015-09

Review 4.  Current concepts on osteonecrosis of the femoral head.

Authors:  Joaquin Moya-Angeler; Arianna L Gianakos; Jordan C Villa; Amelia Ni; Joseph M Lane
Journal:  World J Orthop       Date:  2015-09-18

Review 5.  Avascular Necrosis of Femoral Head-Overview and Current State of the Art.

Authors:  Wojciech Konarski; Tomasz Poboży; Andrzej Śliwczyński; Ireneusz Kotela; Jan Krakowiak; Martyna Hordowicz; Andrzej Kotela
Journal:  Int J Environ Res Public Health       Date:  2022-06-15       Impact factor: 4.614

Review 6.  Conservative surgery for the treatment of osteonecrosis of the femoral head: current options.

Authors:  Elena Gasbarra; Fabio Luigi Perrone; Jacopo Baldi; Vincenzo Bilotta; Antimo Moretti; Umbertto Tarantino
Journal:  Clin Cases Miner Bone Metab       Date:  2016-04-07

7.  Efficacy of autologous stem cell-based therapy for osteonecrosis of the femoral head in sickle cell disease: a five-year follow-up study.

Authors:  Gildasio Cerqueira Daltro; Vitor Fortuna; Eliane Silva de Souza; Marcela Miranda Salles; Ana Claudia Carreira; Roberto Meyer; Songeli Menezes Freire; Radovan Borojevic
Journal:  Stem Cell Res Ther       Date:  2015-05-29       Impact factor: 6.832

8.  Management of femoral head osteonecrosis: Current concepts.

Authors:  Sujit Kumar Tripathy; Tarun Goyal; Ramesh Kumar Sen
Journal:  Indian J Orthop       Date:  2015 Jan-Feb       Impact factor: 1.251

9.  Core decompression and biotechnologies in the treatment of avascular necrosis of the femoral head.

Authors:  Giorgio Maria Calori; Emilio Mazza; Alessandra Colombo; Simone Mazzola; Massimiliano Colombo
Journal:  EFORT Open Rev       Date:  2017-03-13

10.  Use of autologous bone marrow stem cell implantation for osteonecrosis of the knee in sickle cell disease: a preliminary report.

Authors:  Gildasio Daltro; Bruno Adelmo Franco; Thiago Batista Faleiro; Davi Araujo Veiga Rosário; Paula Braga Daltro; Roberto Meyer; Vitor Fortuna
Journal:  BMC Musculoskelet Disord       Date:  2018-05-22       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.